Hepatic Cell News Volume 8.06 | Feb 16 2024

    0
    17








    2024-02-16 | HCN 8.06


    Hepatic Cell News by STEMCELL Technologies
    Vol. 8.06 – 16 February, 2024
    TOP STORY

    Cellular Uptake and In Vivo Distribution of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles Are Protein Corona Dependent

    Scientists explored the impact of protein corona on extracellular vesicles (EVs) derived from two culturing conditions in which specific proteins acquired from media were simultaneously adsorbed on the EV surface.
    [Nature Nanotechnology]

    Full Article
    Access scientific and product support from STEMCELL Technologies
    PUBLICATIONSRanked by the impact factor of the journal

    Asialoglycoprotein Receptor 1 Promotes SARS-CoV-2 Infection of Human Normal Hepatocytes

    Researchers performed a genome-wide CRISPR-Cas9 activation library screening and found that Asialoglycoprotein receptor 1 promoted SARS-CoV-2 pseudovirus infection of HeLa cells.
    [Signal Transduction And Targeted Therapy]

    Full Article

    Sex-Determining Region Y Gene Promotes Liver Fibrosis and Accounts for Sexual Dimorphism in Its Pathophysiology

    Hepatocyte-specific SRY knock-in, SRY knockout, and SRY KI with platelet-derived growth factor receptor α KO mice were generated. Liver fibrosis was induced in mice by bile duct ligation for two weeks or carbon tetrachloride treatment for six weeks.
    [Journal Of Hepatology]

    AbstractGraphical Abstract

    Sonic Hedgehog-Heat Shock Protein 90β Axis Promotes the Development of Nonalcoholic Steatohepatitis in Mice

    The authors found that HSP90β was a key sonic hedgehog (SHH) downstream molecule for promoting NASH process. In hepatocytes, SHH reduces HSP90β ubiquitylation through deubiquitylase USP31, thus preventing HSP90β degradation and promoting hepatic lipid synthesis.
    [Nature Communications]

    Full Article

    p63 Controls Metabolic Activation of Hepatic Stellate Cells and Fibrosis via an HER2-ACC1 Pathway

    TAp63 was induced in hepatic stellate cells from animal models and patients with liver fibrosis and its levels positively correlated with nonalcoholic fatty liver disease activity score and fibrosis stage.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    EGR1 Suppresses HCC Growth and Aerobic Glycolysis by Transcriptionally Downregulating PFKL

    Both in vitro and in vivo assays were employed to examine the impact of early growth response 1 (EGR1) on the growth of HCC. The mouse HCC model and human organoid assay were utilized to assess the potential of EGR1 as a gene therapy for HCC.
    [Journal Of Experimental & Clinical Cancer Research]

    Full Article

    TGFβ-Induced Long Non-Coding RNA LINC00313 Activates Wnt Signaling and Promotes Cholangiocarcinoma

    Gene expression and genome-wide chromatin accessibility profiling reveal that nuclear LINC00313 transcriptionally regulated genes involved in Wnt signaling, such as the transcriptional activator TCF7.
    [EMBO Reports]

    Full ArticleGraphical Abstract

    LncRNA SNHG11 Reprograms Glutaminolysis in Hepatic Stellate Cells via Wnt/β-Catenin/GLS Axis

    Investigators characterized the pro-fibrogenic function of small nucleolar host gene 11 (SNHG11). Their data showed that in carbon tetrachloride treated C57BL/6J mice, SNHG11 expression was highly up-regulated in fibrotic livers and activated primary hepatic stellate cells.
    [Biochemical Pharmacology]

    AbstractGraphical Abstract

    Technical Optimization of Spatially Resolved Single-Cell Transcriptomic Datasets to Study Clinical Liver Disease

    Scientists performed spatial transcriptomics and single nucleus RNA sequencing on matched specimens from patients with either histologically normal or advanced fibrosis to establish important aspects of tissue handling, data processing, and downstream analyses of biobanked liver samples.
    [Scientific Reports]

    Full Article
    A person presenting slides at a scientific conference
    REVIEWS

    Molecular Mechanisms in MASLD/MASH Related HCC

    Investigators delve into metabolic dysfunction-associated steatotic liver disease-HCC associated genetic variations and somatic mutations, disease progression and research models, multi-omics analysis, immunological and microenvironmental impacts.
    [Hepatology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Fred Hutch Launches Rare Cancer Research Effort

    Dr. Taran Gujral and his lab created a drug-matching platform that uses artificial intelligence to help researchers, clinicians and, most importantly, patients find additional uses for drugs that have already gone through clinical trials and received approval from the US FDA.
    [Fred Hutch Cancer Center]

    Press Release

    Treating Liver Cancer with Microrobots Piloted by a Magnetic Field

    Canadian researchers led by Montreal radiologist Gilles Soulez have developed a novel approach to treat liver tumors using magnet-guided microrobots in an MRI device.
    [University of Montreal Hospital (EurekAlert!)]

    Press Release
    FEATURED EVENT

    2024 Cincinnati International Symposium

    April 4 – 5, 2024
    Cincinnati, Ohio, United States

    > See All Events

    JOB OPPORTUNITIES

    Senior Research Nurse – Liver Clinical Trials

    King’s College Hospital – London, England, United Kingdom

    Senior Research Assistant – Epigenetics & Molecular Carcinogenesis

    University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Postdoctoral Research Fellow – T Cell Retention in the Liver

    University College London – London, England, United Kingdom

    PhD Fellow – Viral Hepatitis and Disease Modeling

    University of Antwerp – Antwerp, Belgium

    Research Fellow – Achieving Functional Cure of Chronic Hepatitis B

    National University of Singapore – Singapore, Singapore

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2